Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Continental Resources $1.5 billion notes offering and concurrent tender offers
Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S offering by Continental…
Sizzling Platter $350 million high-yield notes and $65 million credit facility
Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Sizzling Platter, LLC…
Bertelsmann $2.175 billion acquisition of Simon & Schuster
Davis Polk is advising Bertelsmann on the $2.175 billion acquisition by its global trade book publishing group, Penguin…
Sizzling Platter $350 million high-yield notes and $65 million credit facility
Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Sizzling Platter, LLC…
Stericycle $500 million notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by…
FTS International emergence from bankruptcy
Davis Polk advised an ad hoc group of senior secured noteholders in connection with the chapter 11 restructuring of FTS…
FTS International emergence from bankruptcy
Davis Polk advised an ad hoc group of senior secured noteholders in connection with the chapter 11 restructuring of FTS…
Jiya Acquisition $100 million IPO
Davis Polk advised Jiya Acquisition Corp. on its $100 million initial public offering of 10,000,000 shares of Class A common…
Esperion Therapeutics $250 million convertible senior subordinated notes
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Esperion…
Esperion Therapeutics $250 million convertible senior subordinated notes
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Esperion…